ARCHIVES

Cancer Surveillance: risk Factors Explain SF Breast Cancer Rates

This article is from The Cancer Letter archive.

Vol. 23 No. 29 | July 25, 1997

Download PDF Visit The Full Archive

Related Articles

ASCO Releases Guideline On Use Of Growth Factors

May 26, 2006

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

Obey Explains Cuts In Control, Construction Funds; House Passes HEW Appropriations Bill

July 6, 1979

Fraumeni Appointed field Studies Chief

January 18, 1980

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

Journal Editors Were Unaware Of Tobacco Funding.

March 28, 2008